Individual Study / EnCORE

Children and COVID-19: seroprevalence study

Children and COVID-19: seroprevalence study

EnCORE logo
Networks -
Datasets -
Variables -
Start Year
2020
End Year
2023
Visit EnCORE

Members

Download
Investigators Contacts
  • Dr. Jesse Papenburg
    Montreal Children’s Hospital
  • Dr. Kate Zinszer
    University of Montreal, Centre de Recherche CHU Sainte-Justine
  • Dr. Patricia Conrod
    University of Montreal
  • Dr. Gaston DeSerres
    Université Laval
  • Dr. Britt McKinnon
    University of Montreal
  • Dr. Monica Zahreddine
    University of Montreal
  • Dr. Kate Zinszer
    University of Montreal, Centre de Recherche CHU Sainte-Justine

Design

Study design
Cohort
Follow Up
EnCORE is an open cohort and welcomed new children during the longitudinal follow-up. * Round 2 is the first follow up for the children enrolled in Round 1. * Round 3 is the second follow-up for the children that enrolled at Round 1 and the first follow-up for the children that enrolled at Round 2. * Round 4 is the first follow-up for the children enrolled in Round 3, the second follow-up for the children enrolled in Round 2 and the third follow-up for children enrolled in Round 1. * Round 5 is the first follow-up for the children enrolled in Round 4, the second follow-up for the children enrolled in Round 3, the third follow-up for children enrolled in Round 2, and the fourth follow-up for children enrolled in Round 1.

Marker Paper

Zinszer K, McKinnon B, Bourque N, et al. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada. JAMA Netw Open. 2021 Nov 1;4(11):e2135975. doi: 10.1001/jamanetworkopen.2021.35975.

PUBMED 34812845

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
6,671
Number of Participants with Biological Samples
5,300
Supplementary Information

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Populations

Selection Criteria
Minimum age
2
Maximum age
17
Newborns
Twins
Countries
  • Canada
Territory
Montreal (West Island, Hochelaga-Maisonneuve Montréal-Nord, and Plateau)
Ethnic Origin
Health Status
  • Exclusion: * Individuals with chronic disease or other health conditions that preclude participation in the study.
Supplementary Information about selection criteria

Recruitment

Sources of recruitment
  • General population
General Population
  • Selected sample
Supplementary Information
Participants were recruited from the different school boards and daycare associations that operate within the selected neighbourhoods though letters of invitations and social media.

Number of Participants

Number of Participants
4,916
Number of Participants with Biological Samples
4,916
Supplementary Information about selection criteria
All participants who previously participated in the first round were invited to participate in the following rounds. For example, a participant of round 1 can also participate in round 2, 3, 4 and 5.
Data Collection Events
# Name Description Start End
0 EnCORE - Children - Round 1 The parent/guardian is asked to complete an online questionnaire for each participating child. Information on sociodemographics, COVID-19 risk and symptoms in the household, prevention efforts, ... 2020-10 2021-04
2 EnCORE - Children - Round 2 The parent/guardian is asked to complete an online questionnaire for each participating child. Information on socio-demographics, COVID-19 risk and symptoms in the household, and prevention ... 2021-05 2021-09
3 EnCORE - Children - Round 3 The parent/guardian is asked to complete an online questionnaire for each participating child. Information on socio-demographics, COVID-19 risks and symptoms in the household, and prevention ... 2021-11 2022-02
3 EnCORE - Children - Round 4 The parent/guardian is asked to complete an online questionnaire for each participating child. Information on socio-demographics, COVID-19 risks and symptoms in the household, and prevention ... 2022-05 2022-10
4 EnCORE - Children - Round 5 The parent/guardian is asked to complete an online questionnaire for each participating child. Information on socio-demographics, COVID-19 risk and symptoms in the household, and prevention ... 2023-02 2023-05
Selection Criteria
Newborns
Twins
Countries
  • Canada
Territory
Montreal (West Island, Hochelaga-Maisonneuve Montréal-Nord, and Plateau)
Ethnic Origin
Health Status
  • Exclusion: chronic disease or other health conditions that preclude participation in the study

Recruitment

Sources of recruitment
  • Specific population
Specific Population
  • Other specific population : Personnel from the children's daycare and school
Supplementary Information
Participants were recruited from the different school boards and daycare associations that operate within the selected neighbourhoods though letters of invitations and social media.

Number of Participants

Number of Participants
382
Number of Participants with Biological Samples
363
Supplementary Information about selection criteria
95% of participants provided a blood sample for serology analysis.
Data Collection Event
Start Date
2021-03
End Date
2021-08
Data sources
  • Questionnaires
  • Biosamples
Data sources - Biosamples
  • Blood
Selection Criteria
Newborns
Twins
Countries
  • Canada
Territory
Montreal (West Island, Hochelaga-Maisonneuve Montréal-Nord, and Plateau)
Ethnic Origin
Health Status

Recruitment

Sources of recruitment
  • General population
General Population
  • Selected sample
Supplementary Information
Participants are recruited from the children household from the study.

Number of Participants

Number of Participants
1,373
Number of Participants with Biological Samples
Data Collection Event
Start Date
2021-06
End Date
2021-10
Data sources
  • Questionnaires

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information
Cognitive functioning
Personality
Psychological distress and emotions
Other psychological measures and assessments

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Family and household structure
Education
Residence
Birthplace
Ethnicity, race and religion
Language
Labour force and retirement
Income, possessions, and benefits
Other socio-demographic and economic characteristics

Lifestyle and behaviours

Tobacco
Alcohol
Drugs
Nutrition
Physical activity
Transportation
Sleep
Leisure activities
Technological devices
Other and unspecified lifestyle information

Perception of health, quality of life, development and functional limitations

Perception of health
Life course development

Diseases

Certain infectious and parasitic diseases (A00-B99)
Neoplasms (C00-D48)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Endocrine, nutritional and metabolic diseases (E00-E90)
Mental and behavioural disorders (F00-F99)
Diseases of the nervous system (G00-G99)
Diseases of the respiratory system (J00-J99)
Diseases of the skin and subcutaneous tissue (L00-L99)
Diseases of the musculoskeletal system and connective tissue (M00-M99)
Diseases of the genitourinary system (N00-N99)
Certain conditions originating in the perinatal period (P00-P96)
Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
External causes of morbidity and mortality (V01-Y98)
Diseases without precise specification or falling into multiple categories

Symptoms and signs

Symptoms and signs involving the circulatory and respiratory systems (R00-R09)
Symptoms and signs involving the digestive system and abdomen (R10-R19)
Symptoms and signs involving nervous and musculoskeletal systems (R25-R29)
Symptoms and signs involving cognition, perception, emotional state and behaviour (R40-R46)
General symptoms and signs (R50-R69)
Symptoms related to multiple categories

Medication and supplements

Medication and supplement intake
Posology and protocol of administration
Other and unspecified pharmacological interventions

Non-pharmacological interventions

Surgical interventions
Laboratory diagnosis interventions
Other and unspecified non-pharmacological interventions

Health and community care services utilization

Visits to health professionals
Hospitalizations
Community and social care

Physical measures and assessments

Anthropometry

Laboratory measures

Virology
Immunology

Cognition, personality and psychological measures and assessments

Personality
Psychological distress and emotions

Life events, life plans, beliefs and values

Life events
Beliefs and values

Preschool, school and work life

School life
Work life

Social environment and relationships

Social network
Social participation
Social support
Other social environment characteristics

Physical environment

Housing characteristics

Administrative information

Identifiers
Date and time-related information
Questionnaire and interview-related information
Physical and cognitive measure and biosample-related information
Other administrative information

Personality

Brief Resilience Scale
Strengths and Difficulties Questionnaire

Psychological distress and emotions

Goldberg Anxiety and Depression Scales (Anxiety)
Maslach Burnout Inventory - General Survey
Patient Health Questionnaire